2022
DOI: 10.1192/bja.2022.52
|View full text |Cite
|
Sign up to set email alerts
|

Are antidepressants really safe and effective in people with epilepsy and depression?

Abstract: SUMMARY This commentary gives a very brief overview of depression in epilepsy (prevalence, risk, associations between the two conditions, antidepressant medication) and assesses the quality and results of a Cochrane Review comparing antidepressants with placebo and psychotherapy in managing the condition. Although antidepressants were not shown to be more effective than other interventions and no link between antidepressants and increased seizure frequency was observed, the low-quality evidence obtained can… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…The issue opens with a Cochrane Corner summary of the findings Maguire and colleagues’ (2022) review evaluating the efficacy and safety of antidepressants for treating depressive symptoms in people with epilepsy and depression and the effect on seizures, which is followed by with a commentary by Makan (2022).…”
Section: This Issuementioning
confidence: 99%
“…The issue opens with a Cochrane Corner summary of the findings Maguire and colleagues’ (2022) review evaluating the efficacy and safety of antidepressants for treating depressive symptoms in people with epilepsy and depression and the effect on seizures, which is followed by with a commentary by Makan (2022).…”
Section: This Issuementioning
confidence: 99%